Publications by authors named "Sarah Keidel"

Claim this Profile
U
Unraveling Relatlimab-Specific Biology Using Biomarker Analyses in Patients with Advanced Melanoma in RELATIVITY-047.
Evan J Lipson, Sonia Dolfi, Hao Tang, Hussein A Tawbi, Francisco Medina-Soto, Sarah Keidel

Clin Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial Data.
Georgina V Long, Evan J Lipson, F Stephen Hodi, Paolo A Ascierto, James Larkin, Sarah Keidel

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial Data.
Georgina V Long, Evan J Lipson, F Stephen Hodi, Paolo A Ascierto, James Larkin, Sarah Keidel

J Clin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-Informed Clinical Pharmacology Profile of a Novel Fixed-Dose Combination of Nivolumab and Relatlimab in Adult and Adolescent Patients with Solid Tumors.
Yue Zhao, Zheyi Hu, Sai Praneeth Bathena, Sarah Keidel, Karen Miller-Moslin

Clin Cancer Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life with nivolumab plus relatlimab versus nivolumab monotherapy in patients with previously untreated unresectable or metastatic melanoma: RELATIVITY-047 trial.
Dirk Schadendorf, Hussein Tawbi, Evan J Lipson, F Stephen Hodi, Piotr Rutkowski, Sarah Keidel

Eur J Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Survival and Response with Nivolumab and Relatlimab in Advanced Melanoma.
Georgina V Long, F Stephen Hodi, Evan J Lipson, Dirk Schadendorf, Paolo A Ascierto, Sarah Keidel

NEJM Evid· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.
Hussein A Tawbi, Dirk Schadendorf, Evan J Lipson, Paolo A Ascierto, Luis Matamala, Sarah Keidel

N Engl J Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The RA-MAP Consortium: a working model for academia-industry collaboration.
Andrew P Cope, Michael R Barnes, Alexandra Belson, Michael Binks, Sarah Brockbank, Sarah Keidel

Nat Rev Rheumatol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaboration.
Andrew P Cope, Michael R Barnes, Alexandra Belson, Michael Binks, Sarah Brockbank, Sarah Keidel

Nat Rev Rheumatol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of rheumatologist-performed ultrasound on diagnosis and management of inflammatory arthritis in routine clinical practice.
Stephen Kelly, Brian Davidson, Sarah Keidel, Stephan Gadola, Claire Gorman

BMC Musculoskelet Disord· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of tocilizumab for interstitial lung disease in an undifferentiated autoinflammatory disorder partially responsive to anakinra.
Sarah M Keidel, Rachel K Hoyles, Nick M R Wilkinson

Rheumatology (Oxford)· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERAP1 and ankylosing spondylitis.
Sarah Keidel, Liye Chen, Jennifer Pointon, Paul Wordsworth

Curr Opin Immunol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis.
Sravan K Payeli, Simon Kollnberger, Osiris Marroquin Belaunzaran, Markus Thiel, Kirsty McHugh, Sarah Keidel

Arthritis Rheum· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sweet's syndrome after adalimumab therapy for refractory relapsing polychondritis.
Sarah Keidel, Aubretia McColl, Sally Edmonds

BMJ Case Rep· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis